The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group.

BACKGROUND Hepatitis G virus (HGV) or GBV-C is frequently detected in patients co-infected with hepatitis C virus (HCV). This study investigated host and virologic factors influencing the response to HGV/GBV-C to alpha-interferon treatment. METHODS HGV/GBV-C was detected and quantified by nested polymerase chain reaction. The influence of variables such as liver biopsy appearance, liver function abnormalities, and response of HCV to interferon treatment was monitored. RESULTS Fourteen of the 25 HGV/GBV-C-infected patients treated with interferon (3-6 MIU three times a week for 6 months) became non-viraemic during treatment, although all relapsed after treatment withdrawal at 6 months, with no net change in virus load between 0 and 12 months. CONCLUSIONS Predictive factors for clearance of HGV/GBV-C viraemia by interferon were pre-treatment severity of liver disease (median Knodell score of 4, compared with 7 for non-responders; P = 0.030) and alanine aminotransferase levels (median, 114, 182 for non-responders; P = 0.039). Clearance was associated with the treatment response of HCV. Nine of 13 who cleared HGV/GBV-C also cleared HCV, compared with 3 of 11 HGV/GBV-C non-responders; P = 0.05). The shared susceptibility of HGV/GBV-C and HCV to interferon treatment suggests a link between the mechanism of clearance of the two viruses.

[1]  P. Simmonds,et al.  Patterns of Hepatitis G Viraemia and Liver Disease in Haemophiliacs Previously Exposed to Non-virus Inactivated Coagulation Factor Concentrates , 1998, Thrombosis and Haemostasis.

[2]  J. Rakela,et al.  Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses , 1997, Journal of virology.

[3]  M. Houghton,et al.  Effects of interferon treatment on the antiviral T‐cell response in hepatitis C virus genotype 1b‐ and genotype 2c‐infected patients , 1997, Hepatology.

[4]  T. Morishima,et al.  Hepatitis G infection. , 1997, The New England journal of medicine.

[5]  M. Clementi,et al.  Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis. , 1997, Journal of hepatology.

[6]  H. Okamoto,et al.  Effect of interferon on GB virus C and hepatitis C virus in hepatitis patients with the co‐infection , 1997, Journal of medical virology.

[7]  P. Marcellin,et al.  Influence of Hepatitis G Virus Infection on the Severity of Liver Disease and Response to Interferon- in Patients with Chronic Hepatitis C , 1997, Annals of Internal Medicine.

[8]  X. Forns,et al.  Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. , 1997, Journal of hepatology.

[9]  R. Wesley,et al.  The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. , 1997, The New England journal of medicine.

[10]  H. Margolis,et al.  Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. , 1997, The New England journal of medicine.

[11]  S. Iino,et al.  Effect of interferon therapy on RNA of GB virus C in the patients with chronic hepatitis who were co-infected with hepatitis C virus , 1997 .

[12]  I. Kay,et al.  LOW PREVALENCE OF HEPATITIS G VIRAEMIA IN HAEMOPHILIA PATIENTS IN AUSTRALIA , 1997, British journal of haematology.

[13]  P. Simmonds,et al.  The clinical significance of the detection of hepatitis GBV‐C RNA in the serum of patients with fulminant, presumed viral, hepatitis , 1997, Journal of viral hepatitis.

[14]  J. Tran van Nhieu,et al.  Histopathologic impact of GB virus C infection on chronic hepatitis C. , 1997, Gastroenterology.

[15]  S. Harthug,et al.  Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. , 1997, Scandinavian journal of infectious diseases.

[16]  P. Simmonds,et al.  Infection with hepatitis G virus among recipients of plasma products , 1996, The Lancet.

[17]  T. Berg,et al.  Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. , 1996, Journal of hepatology.

[18]  E. Tanaka,et al.  Effect of Hepatitis G Virus Infection on Chronic Hepatitis C , 1996, Annals of Internal Medicine.

[19]  M. Biasin,et al.  Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection , 1996, The Lancet.

[20]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[21]  Ding‐Shinn Chen,et al.  GBV-C in the aetiology of fulminant hepatitis , 1996, The Lancet.

[22]  T. Pilot‐Matias,et al.  Sequence and genomic organization of GBV‐C: A novel member of the flaviviridae associated with human non‐A‐E hepatitis , 1996, Journal of medical virology.

[23]  S. Mishiro,et al.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology , 1995, The Lancet.

[24]  T. Pilot‐Matias,et al.  Origin of GB-hepatitis viruses , 1995, The Lancet.

[25]  T. Pilot‐Matias,et al.  Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.

[26]  P. Simmonds,et al.  Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. , 1995, The Journal of general virology.

[27]  P. Simmonds,et al.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 , 1993, Journal of clinical microbiology.

[28]  P. Simmonds,et al.  Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users , 1990, The Lancet.

[29]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.